Quantum Biopharma Class B Subordinate Voting Shares
QNTM
13 hedge funds and large institutions have $549K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
5,800% more call options, than puts
Call options by funds: $59K | Put options by funds: $1K
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
18% more funds holding
Funds holding: 11 → 13 (+2)
6% more capital invested
Capital invested by funds: $516K → $549K (+$32.3K)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$23K |
| 2 |
Jane Street
New York
|
+$21.5K |
| 3 |
HF
HRT Financial
New York
|
+$13.8K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$13.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$42.7K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$17.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$11.7K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.55K |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$82 |
QNTM Hedge Fund Activity: Q3 2023 in Review
13 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2023, worth a combined $549K — up 6.3% from $516K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new QNTM positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Group One Trading, opening a new position worth an estimated $23K. The largest seller was Renaissance Technologies, cutting an estimated $42.7K.
- 13 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2023, up from 11 in Q2 2023.
- Funds reported $549K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2023, up 6.3% quarter-over-quarter.
- 4 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2023 and 2 closed out, a net change of +2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2023 was Group One Trading, an estimated $23K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2023 was Renaissance Technologies, an estimated $42.7K sold.
Based on aggregated 13F filings for Q3 2023.